Showing 71-75 of 93 predictive & prescriptive analytics:
OM1 Launches Multiple Sclerosis Registry With More Than 20,000 Patients Prospectively Followed With Deep Clinical Data

BOSTON, July 14, 2021 /PRNewswire/ — OM1, a leading real-world data, outcomes and technology company with a focus on chronic diseases, today announced the launch of its multiple sclerosis (MS) registry. MS is an auto-immune, inflammatory disease that attacks the central nervous system (CNS) and causes a variety of neurological symptoms, such as muscle weakness, spasticity, fatigue, numbness, vision[…]

CNS & Behavioral Health: Using RWD to Accelerate Research & Improve Outcomes

Tue, Jun 22, 2021 2:00 PM – 3:00 PM EDT Register >> Nearly 20% of Americans are diagnosed with a mental health condition every year. Yet, more than half of those don’t receive a treatment for their condition. Globally, neurological disorders are one of the leading causes of disability and death with few if any[…]

Bridging Clinical Research with Clinical Practice: Use of AI in Predicting Outcomes

Wed, May 18, 2021 11:00 AM – 12:00 PM EDT Register Artificial Intelligence (AI) is increasingly being applied to improve medical research and clinical practice. Join this panelist discussion exploring AI applications and high-performance predictive modeling for: – Improving research efficiency – Accelerating personalized treatment development – Supporting clinical decision making Presenters: – Prakash Jayakumar,[…]

Real-World Data and External Control Arms 101

Thu, Apr 29, 2021 11:30 AM – 12:30 PM EDT Register Real-world data is increasingly being used to develop external control arms for trial planning and regulatory submissions. Understanding the basics of what they are and how they can be used effectively are critical to success. Join Dr. Richard Gliklich, CEO of OM1, as he[…]

1 … 13 14 15 16 17 … 19